Literature DB >> 10718548

Excess iodine induces apoptosis in the thyroid of goitrogen-pretreated rats in vivo.

R B Burikhanov1, S Matsuzaki.   

Abstract

Previously, we observed that excess iodide rapidly suppressed the elevated ornithine decarboxylase activity in the thyroid of propylthiouracil (PTU)-pretreated rats. Excess iodide also induces involution of goitrous thyroids. These findings led us to study effects of excess iodide on apoptosis of rat thyroids. When given to PTU-pretreated rats, excess potassium iodide (KI) (13 mg/kg body weight, 10 mg as iodine) induced DNA fragmentation in the thyroid at the first 3 hours after its treatment. The percentage of DNA fragmentation was also maximal at 3 hours after KI treatment. In methimazole-pretreated rats, the kinetic of DNA fragmentation was nearly the same; apoptosis increased for the first 6 hours and then decreased at 12 hours after KI administration. Other iodinated compounds such as amiodarone and diiodotyrosine have also shown apoptosis-inducing activity, but their effect was observed later than KI. Iopanoic acid had no such effect. Apoptotic changes were also observed with the use of flow cytometry. PTU or methimazole alone had some stimulatory effect on thyroid apoptosis. Iodine effect was not observed in rats treated with either perchlorate or thiocyanate. These results suggest that excess iodine induces thyroid involution in goitrogen-treated rats at least partially by apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718548     DOI: 10.1089/thy.2000.10.123

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

1.  Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).

Authors:  F Soriguer; P Santiago; L Vila; J M Arena; E Delgado; F Díaz Cadórniga; S Donnay; M Fernández Soto; S González-Romero; P Martul; M Puig Domingo; S Ares; F Escobar del Rey; G Morreale de Escobar
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

2.  Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals.

Authors:  Shakila Sabir; Muhammad Furqan Akhtar; Ammara Saleem
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-22       Impact factor: 4.223

3.  Graves' ophthalmopathy: a review of immunogenetics.

Authors:  Omid Khalilzadeh; Sina Noshad; Armin Rashidi; Aliakbar Amirzargar
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

4.  Proteomic profiling of thyroid tissue in patients with obesity and benign diffuse goiter.

Authors:  Hicham Benabdelkamel; Mohamed Rafiullah; Afshan Masood; Abdulaziz Alsaif; Mohthash Musambil; Assim A Alfadda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.